127 related articles for article (PubMed ID: 19958646)
21. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
Bays HE; Ose L; Fraser N; Tribble DL; Quinto K; Reyes R; Johnson-Levonas AO; Sapre A; Donahue SR;
Clin Ther; 2004 Nov; 26(11):1758-73. PubMed ID: 15639688
[TBL] [Abstract][Full Text] [Related]
22. The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy.
Parra D; Beckey NP; Stevens GR
Pharmacotherapy; 2007 May; 27(5):675-83. PubMed ID: 17461702
[TBL] [Abstract][Full Text] [Related]
23. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking.
Nyblom H; Berggren U; Balldin J; Olsson R
Alcohol Alcohol; 2004; 39(4):336-9. PubMed ID: 15208167
[TBL] [Abstract][Full Text] [Related]
24. Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial.
Nuki G; Bresnihan B; Bear MB; McCabe D;
Arthritis Rheum; 2002 Nov; 46(11):2838-46. PubMed ID: 12428223
[TBL] [Abstract][Full Text] [Related]
25. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial.
Aller R; De Luis DA; Izaola O; Conde R; Gonzalez Sagrado M; Primo D; De La Fuente B; Gonzalez J
Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1090-5. PubMed ID: 22013734
[TBL] [Abstract][Full Text] [Related]
26. Effects of magnesium isoglycyrrhizinate on AST, ALT, and serum levels of Th1 cytokines in patients with allo-HSCT.
Lv J; Xiao Q; Chen Y; Fan X; Liu X; Liu F; Luo G; Zhang B; Wang S
Int Immunopharmacol; 2017 May; 46():56-61. PubMed ID: 28259001
[TBL] [Abstract][Full Text] [Related]
27. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group.
Tassopoulos NC; Volpes R; Pastore G; Heathcote J; Buti M; Goldin RD; Hawley S; Barber J; Condreay L; Gray DF
Hepatology; 1999 Mar; 29(3):889-96. PubMed ID: 10051494
[TBL] [Abstract][Full Text] [Related]
29. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
[TBL] [Abstract][Full Text] [Related]
30. Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study.
Manosuthi W; Chumpathat N; Chaovavanich A; Sungkanuparph S
BMC Infect Dis; 2005 Aug; 5():67. PubMed ID: 16120209
[TBL] [Abstract][Full Text] [Related]
31. Magnesium isoglycyrrhizinate inhibits inflammatory response through STAT3 pathway to protect remnant liver function.
Tang GH; Yang HY; Zhang JC; Ren JJ; Sang XT; Lu X; Zhong SX; Mao YL
World J Gastroenterol; 2015 Nov; 21(43):12370-80. PubMed ID: 26604644
[TBL] [Abstract][Full Text] [Related]
32. Hepatoprotective Effects of a Proprietary Glycyrrhizin Product during Alcohol Consumption: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
Chigurupati H; Auddy B; Biyani M; Stohs SJ
Phytother Res; 2016 Dec; 30(12):1943-1953. PubMed ID: 27539273
[TBL] [Abstract][Full Text] [Related]
33. The efficacy of licorice root extract in decreasing transaminase activities in non-alcoholic fatty liver disease: a randomized controlled clinical trial.
Hajiaghamohammadi AA; Ziaee A; Samimi R
Phytother Res; 2012 Sep; 26(9):1381-4. PubMed ID: 22308054
[TBL] [Abstract][Full Text] [Related]
34. Effect of folic acid intervention on ALT concentration in hypertensives without known hepatic disease: a randomized, double-blind, controlled trial.
Qin X; Li J; Cui Y; Liu Z; Zhao Z; Ge J; Guan D; Hu J; Wang Y; Zhang F; Xu X; Wang X; Xu X; Huo Y
Eur J Clin Nutr; 2012 May; 66(5):541-8. PubMed ID: 22085872
[TBL] [Abstract][Full Text] [Related]
35. [Effect of magnesium isoglycyrrhizinate on concanavalin A (Con A)-induced immunological liver injury in mice].
JIN J; XU JM; LIU XC; MEI Q
Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):389-90. PubMed ID: 19497210
[No Abstract] [Full Text] [Related]
36. Magnesium Isoglycyrrhizinate attenuates lipopolysaccharide-induced depressive-like behavior in mice.
Jiang W; Chen Q; Li P; Lu Q; Pei X; Sun Y; Wang G; Hao K
Biomed Pharmacother; 2017 Feb; 86():177-184. PubMed ID: 27978497
[TBL] [Abstract][Full Text] [Related]
37. Hepatotoxicity and liver enzyme alteration in patients with immunobullous diseases receiving immunosuppressive therapy.
Shahshahani MM; Azizahari S; Soori T; Manavi S; Balighi K; Daneshpazhooh M; Davatchi CS; Esmaili N
J Dermatol; 2011 Dec; 38(12):1153-7. PubMed ID: 21981904
[TBL] [Abstract][Full Text] [Related]
38. [Dynamics of antipirin test at patients with alcoholic liver disease on the background of metadoksin drug receiving].
Sil'vestrova SIu; Fedotova SIu; Drozdov TF; Petrakov AV
Eksp Klin Gastroenterol; 2011; (6):32-7. PubMed ID: 22168075
[TBL] [Abstract][Full Text] [Related]
39. The effect of 1g of acetaminophen twice daily for 12 weeks on alanine transaminase levels--A randomized placebo-controlled trial.
Ioannides SJ; Siebers R; Perrin K; Weatherall M; Crane J; Travers J; Shirtcliffe P; Beasley R
Clin Biochem; 2015 Jul; 48(10-11):713-5. PubMed ID: 25899926
[TBL] [Abstract][Full Text] [Related]
40. Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks.
Manns MP; Wedemeyer H; Singer A; Khomutjanskaja N; Dienes HP; Roskams T; Goldin R; Hehnke U; Inoue H;
J Viral Hepat; 2012 Aug; 19(8):537-46. PubMed ID: 22762137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
